Abraha Iosief, Luchetta Maria Laura, De Florio Rita, Cozzolino Francesco, Casazza Giovanni, Duca Piergiorgio, Parente Basso, Orso Massimiliano, Germani Antonella, Eusebi Paolo, Montedori Alessandro
Health Planning Service, Regional Health Authority of Umbria, Perugia, Italy, 06124.
Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD010296. doi: 10.1002/14651858.CD010296.pub2.
People with abdominal aortic aneurysm who receive endovascular aneurysm repair (EVAR) need lifetime surveillance to detect potential endoleaks. Endoleak is defined as persistent blood flow within the aneurysm sac following EVAR. Computed tomography (CT) angiography is considered the reference standard for endoleak surveillance. Colour duplex ultrasound (CDUS) and contrast-enhanced CDUS (CE-CDUS) are less invasive but considered less accurate than CT.
To determine the diagnostic accuracy of colour duplex ultrasound (CDUS) and contrast-enhanced-colour duplex ultrasound (CE-CDUS) in terms of sensitivity and specificity for endoleak detection after endoluminal abdominal aortic aneurysm repair (EVAR).
We searched MEDLINE, Embase, LILACS, ISI Conference Proceedings, Zetoc, and trial registries in June 2016 without language restrictions and without use of filters to maximize sensitivity.
Any cross-sectional diagnostic study evaluating participants who received EVAR by both ultrasound (with or without contrast) and CT scan assessed at regular intervals.
Two pairs of review authors independently extracted data and assessed quality of included studies using the QUADAS 1 tool. A third review author resolved discrepancies. The unit of analysis was number of participants for the primary analysis and number of scans performed for the secondary analysis. We carried out a meta-analysis to estimate sensitivity and specificity of CDUS or CE-CDUS using a bivariate model. We analysed each index test separately. As potential sources of heterogeneity, we explored year of publication, characteristics of included participants (age and gender), direction of the study (retrospective, prospective), country of origin, number of CDUS operators, and ultrasound manufacturer.
We identified 42 primary studies with 4220 participants. Twenty studies provided accuracy data based on the number of individual participants (seven of which provided data with and without the use of contrast). Sixteen of these studies evaluated the accuracy of CDUS. These studies were generally of moderate to low quality: only three studies fulfilled all the QUADAS items; in six (40%) of the studies, the delay between the tests was unclear or longer than four weeks; in eight (50%), the blinding of either the index test or the reference standard was not clearly reported or was not performed; and in two studies (12%), the interpretation of the reference standard was not clearly reported. Eleven studies evaluated the accuracy of CE-CDUS. These studies were of better quality than the CDUS studies: five (45%) studies fulfilled all the QUADAS items; four (36%) did not report clearly the blinding interpretation of the reference standard; and two (18%) did not clearly report the delay between the two tests.Based on the bivariate model, the summary estimates for CDUS were 0.82 (95% confidence interval (CI) 0.66 to 0.91) for sensitivity and 0.93 (95% CI 0.87 to 0.96) for specificity whereas for CE-CDUS the estimates were 0.94 (95% CI 0.85 to 0.98) for sensitivity and 0.95 (95% CI 0.90 to 0.98) for specificity. Regression analysis showed that CE-CDUS was superior to CDUS in terms of sensitivity (LR Chi = 5.08, 1 degree of freedom (df); P = 0.0242 for model improvement).Seven studies provided estimates before and after administration of contrast. Sensitivity before contrast was 0.67 (95% CI 0.47 to 0.83) and after contrast was 0.97 (95% CI 0.92 to 0.99). The improvement in sensitivity with of contrast use was statistically significant (LR Chi = 13.47, 1 df; P = 0.0002 for model improvement).Regression testing showed evidence of statistically significant effect bias related to year of publication and study quality within individual participants based CDUS studies. Sensitivity estimates were higher in the studies published before 2006 than the estimates obtained from studies published in 2006 or later (P < 0.001); and studies judged as low/unclear quality provided higher estimates in sensitivity. When regression testing was applied to the individual based CE-CDUS studies, none of the items, namely direction of the study design, quality, and age, were identified as a source of heterogeneity.Twenty-two studies provided accuracy data based on number of scans performed (of which four provided data with and without the use of contrast). Analysis of the studies that provided scan based data showed similar results. Summary estimates for CDUS (18 studies) showed 0.72 (95% CI 0.55 to 0.85) for sensitivity and 0.95 (95% CI 0.90 to 0.96) for specificity whereas summary estimates for CE-CDUS (eight studies) were 0.91 (95% CI 0.68 to 0.98) for sensitivity and 0.89 (95% CI 0.71 to 0.96) for specificity.
AUTHORS' CONCLUSIONS: This review demonstrates that both ultrasound modalities (with or without contrast) showed high specificity. For ruling in endoleaks, CE-CDUS appears superior to CDUS. In an endoleak surveillance programme CE-CDUS can be introduced as a routine diagnostic modality followed by CT scan only when the ultrasound is positive to establish the type of endoleak and the subsequent therapeutic management.
接受腹主动脉瘤腔内修复术(EVAR)的腹主动脉瘤患者需要终身监测,以检测潜在的内漏。内漏定义为EVAR术后动脉瘤腔内持续的血流。计算机断层扫描(CT)血管造影被认为是内漏监测的参考标准。彩色双功超声(CDUS)和对比增强CDUS(CE-CDUS)侵入性较小,但被认为比CT准确性低。
确定彩色双功超声(CDUS)和对比增强彩色双功超声(CE-CDUS)在腔内腹主动脉瘤修复术(EVAR)后检测内漏的敏感性和特异性方面的诊断准确性。
我们于2016年6月检索了MEDLINE、Embase、LILACS、ISI会议论文集、Zetoc和试验注册库,没有语言限制,也未使用筛选器以最大化敏感性。
任何横断面诊断研究,评估通过超声(有无对比剂)和定期CT扫描接受EVAR的参与者。
两对综述作者独立提取数据,并使用QUADAS-1工具评估纳入研究的质量。第三位综述作者解决分歧。分析单位在主要分析中为参与者数量,在次要分析中为扫描次数。我们进行了一项荟萃分析,使用双变量模型估计CDUS或CE-CDUS的敏感性和特异性。我们分别分析每个指标测试。作为潜在的异质性来源,我们探讨了发表年份、纳入参与者的特征(年龄和性别)、研究方向(回顾性、前瞻性)、原产国、CDUS操作者数量和超声设备制造商。
我们确定了42项纳入4220名参与者的原始研究。20项研究基于个体参与者数量提供了准确性数据(其中7项研究提供了使用对比剂和未使用对比剂的数据)。其中16项研究评估了CDUS的准确性。这些研究质量一般为中等或较低:只有3项研究满足所有QUADAS条目;在6项(40%)研究中,两次检查之间的间隔不明确或超过四周;在8项(50%)研究中,未明确报告指标测试或参考标准的盲法情况或未实施盲法;在2项(12%)研究中,未明确报告参考标准的解读情况。11项研究评估了CE-CDUS的准确性。这些研究质量优于CDUS研究:5项(45%)研究满足所有QUADAS条目;4项(36%)未明确报告参考标准的盲法解读情况;2项(18%)未明确报告两次检查之间的间隔。基于双变量模型,CDUS的敏感性汇总估计值为0.82(95%置信区间(CI)0.66至0.91),特异性为其0.93(95%CI 0.87至0.96),而CE-CDUS的敏感性估计值为0.94(95%CI 0.85至0.98),特异性为0.95(95%CI 0.90至0.98)。回归分析表明,CE-CDUS在敏感性方面优于CDUS(似然比卡方检验=5.08,1自由度(df);模型改进P=0.0242)。7项研究提供了使用对比剂前后的估计值。使用对比剂前的敏感性为0.67(95%CI 0.47至0.83),使用对比剂后的敏感性为0.97(95%CI 0.92至0.99)。使用对比剂后敏感性的提高具有统计学意义(似然比卡方检验=13.47,1 df;模型改进P=0.0002)。回归检验显示,基于个体参与者的CDUS研究中,存在与发表年份和研究质量相关的统计学显著效应偏倚证据。2006年之前发表的研究的敏感性估计值高于2006年或之后发表的研究(P<0.001);被判定为低质量/质量不明确的研究提供的敏感性估计值更高。当对基于个体参与者的CE-CDUS研究进行回归检验时,未发现研究设计方向、质量和年龄等项目是异质性来源。22项研究基于扫描次数提供了准确性数据(其中4项研究提供了使用对比剂和未使用对比剂的数据)。对提供基于扫描数据的研究分析显示了相似的结果。CDUS(18项研究)的敏感性汇总估计值为0.72(95%CI 0.55至0.85),特异性为0.95(95%CI 0.90至0.96),而CE-CDUS(8项研究)的敏感性汇总估计值为0.91(95%CI 0.68至0.98),特异性为0.89(95%CI 0.71至0.96)。
本综述表明两种超声检查方式(有无对比剂)均显示出高特异性。对于确诊内漏,CE-CDUS似乎优于CDUS。在一项内漏监测计划中,CE-CDUS可作为常规诊断方式引入,仅在超声检查呈阳性时进行CT扫描,以确定内漏类型及后续治疗管理。